ATE98689T1 - Immobilisierungsverfahren. - Google Patents
Immobilisierungsverfahren.Info
- Publication number
- ATE98689T1 ATE98689T1 AT88306038T AT88306038T ATE98689T1 AT E98689 T1 ATE98689 T1 AT E98689T1 AT 88306038 T AT88306038 T AT 88306038T AT 88306038 T AT88306038 T AT 88306038T AT E98689 T1 ATE98689 T1 AT E98689T1
- Authority
- AT
- Austria
- Prior art keywords
- immobilization procedure
- immobilization
- polyazetidine
- coenzymes
- dewatering
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 239000005515 coenzyme Substances 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C12N11/091—Phenol resins; Amino resins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/098—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer formed in the presence of the enzymes or microbial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
- C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK336987A DK336987D0 (da) | 1987-07-01 | 1987-07-01 | Immobiliseringsmetode |
| EP88306038A EP0297912B1 (de) | 1987-07-01 | 1988-06-30 | Immobilisierungsverfahren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE98689T1 true ATE98689T1 (de) | 1994-01-15 |
Family
ID=8122094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88306038T ATE98689T1 (de) | 1987-07-01 | 1988-06-30 | Immobilisierungsverfahren. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0297912B1 (de) |
| JP (1) | JP2641934B2 (de) |
| KR (1) | KR970000186B1 (de) |
| AT (1) | ATE98689T1 (de) |
| DE (1) | DE3886280T2 (de) |
| DK (2) | DK336987D0 (de) |
| ES (1) | ES2061656T3 (de) |
| WO (1) | WO1989000195A1 (de) |
Families Citing this family (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI85384C (fi) * | 1989-09-06 | 1992-04-10 | Cultor Oy | Foerfarande foer hydrolysering av hemicellulosa med immobiliserade enzymer och produkt som omfattar ett immobiliserat hemicellulolytiskt enzym. |
| DK589389D0 (da) * | 1989-11-23 | 1989-11-23 | Novo Nordisk As | Immobiliseret enzympraeparat |
| AT401653B (de) * | 1994-10-05 | 1996-11-25 | Avl Verbrennungskraft Messtech | Verfahren zur immobilisierung biologischer komponenten in einer polymermatrix sowie biosensoren unter verwendung derartiger immobilisate |
| US6060268A (en) * | 1995-07-18 | 2000-05-09 | Gist-Brocades B.V. | Penicillin G acylase immobilized with a crosslinked mixture of gelled gelatin and amino polymer |
| CN1165616C (zh) * | 1995-07-18 | 2004-09-08 | 吉斯特·布罗卡迪斯股份有限公司 | 一种改进的固定化青霉素g酰基转移酶 |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
| JP5183484B2 (ja) | 2005-12-09 | 2013-04-17 | ユセベ ファルマ ソシエテ アノニム | ヒトｉｌ−６に対して特異性を有する抗体分子 |
| GB0620729D0 (en) | 2006-10-18 | 2006-11-29 | Ucb Sa | Biological products |
| GB0807413D0 (en) | 2008-04-23 | 2008-05-28 | Ucb Pharma Sa | Biological products |
| EP2398498B1 (de) | 2009-02-17 | 2018-09-05 | UCB Biopharma SPRL | Für humanes ox40 spezifische antikörpermoleküle |
| GB0904214D0 (en) | 2009-03-11 | 2009-04-22 | Ucb Pharma Sa | Biological products |
| ES2667258T3 (es) | 2009-09-10 | 2018-05-10 | Ucb Biopharma Sprl | Anticuerpos multivalentes |
| GB0920127D0 (en) | 2009-11-17 | 2009-12-30 | Ucb Pharma Sa | Antibodies |
| GB0920324D0 (en) | 2009-11-19 | 2010-01-06 | Ucb Pharma Sa | Antibodies |
| GB201000467D0 (en) | 2010-01-12 | 2010-02-24 | Ucb Pharma Sa | Antibodies |
| TW201134488A (en) | 2010-03-11 | 2011-10-16 | Ucb Pharma Sa | PD-1 antibodies |
| CA2791930A1 (en) | 2010-03-11 | 2011-09-15 | Kerry Louise Tyson | Pd-1 antibody |
| ES2717883T3 (es) | 2010-03-25 | 2019-06-26 | Ucb Biopharma Sprl | Moléculas de DVD-LG estabilizadas con disulfuro |
| GB201005064D0 (en) | 2010-03-25 | 2010-05-12 | Ucb Pharma Sa | Biological products |
| GB201014033D0 (en) | 2010-08-20 | 2010-10-06 | Ucb Pharma Sa | Biological products |
| ME02734B (de) | 2011-01-14 | 2017-10-20 | Ucb Biopharma Sprl | Antikörpermodule zur bindung an il-17a und il-17f |
| US10752676B2 (en) | 2011-09-16 | 2020-08-25 | Ucb Biopharma Sprl | Neutralising antibodies to the major exotoxins TCDA and TCDB of Clostridium difficile |
| UA112203C2 (uk) | 2011-11-11 | 2016-08-10 | Юсб Фарма С.А. | Злитий білок біоспецифічного антитіла, який зв'язується з ox40 людини та сироватковим альбуміном людини |
| GB201203071D0 (en) | 2012-02-22 | 2012-04-04 | Ucb Pharma Sa | Biological products |
| GB201203051D0 (en) | 2012-02-22 | 2012-04-04 | Ucb Pharma Sa | Biological products |
| GB201208370D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Antibodies |
| CN102758289A (zh) * | 2012-08-06 | 2012-10-31 | 天津工业大学 | 一种用于细胞固定化的机织物载体及其制备方法 |
| GB201223276D0 (en) | 2012-12-21 | 2013-02-06 | Ucb Pharma Sa | Antibodies and methods of producing same |
| GB201315487D0 (en) | 2013-08-30 | 2013-10-16 | Ucb Pharma Sa | Antibodies |
| GB201320066D0 (en) | 2013-11-13 | 2013-12-25 | Ucb Pharma Sa | Biological products |
| GB201409558D0 (en) | 2014-05-29 | 2014-07-16 | Ucb Biopharma Sprl | Method |
| GB201411320D0 (en) | 2014-06-25 | 2014-08-06 | Ucb Biopharma Sprl | Antibody construct |
| GB201412658D0 (en) | 2014-07-16 | 2014-08-27 | Ucb Biopharma Sprl | Molecules |
| GB201412659D0 (en) | 2014-07-16 | 2014-08-27 | Ucb Biopharma Sprl | Molecules |
| GB201506869D0 (en) | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
| GB201506870D0 (en) | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
| JP2018515082A (ja) | 2015-04-30 | 2018-06-14 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 代謝障害を処置するための抗ａｐ２抗体及び抗原結合剤 |
| GB201508180D0 (en) | 2015-05-13 | 2015-06-24 | Ucb Biopharma Sprl | Antibodies |
| CN113940996A (zh) | 2015-05-27 | 2022-01-18 | Ucb生物制药私人有限公司 | 用于治疗神经系统疾病的方法 |
| MA41670A1 (fr) | 2015-07-06 | 2018-05-31 | Ucb Biopharma Sprl | Anticorps se liant a tau |
| GB201601073D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibodies |
| GB201601075D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibodies molecules |
| GB201601077D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibody molecule |
| RU2754683C2 (ru) | 2015-10-27 | 2021-09-06 | Юсб Биофарма Срл | Способы лечения с использованием анти-il-17a антител |
| GB201521389D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Method |
| GB201521382D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201521383D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl And Ucb Celltech | Method |
| GB201521391D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201521393D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201522394D0 (en) | 2015-12-18 | 2016-02-03 | Ucb Biopharma Sprl | Antibodies |
| WO2017213695A1 (en) | 2016-06-07 | 2017-12-14 | The Brigham And Women's Hospital, Inc. | Compositions and methods relating to t peripheral helper cells in autoantibody-associated conditions |
| GB201610198D0 (en) | 2016-06-10 | 2016-07-27 | Ucb Biopharma Sprl | Anti-ige antibodies |
| SG10201913858WA (en) | 2016-08-26 | 2020-03-30 | Agency Science Tech & Res | Macrophage stimulating protein receptor (or ron - recepteur d' origine nantais) antibodies and uses thereof |
| GB201616596D0 (en) | 2016-09-29 | 2016-11-16 | Nascient Limited | Epitope and antibodies |
| GB201621635D0 (en) | 2016-12-19 | 2017-02-01 | Ucb Biopharma Sprl | Crystal structure |
| WO2018183366A1 (en) | 2017-03-28 | 2018-10-04 | Syndax Pharmaceuticals, Inc. | Combination therapies of csf-1r or csf-1 antibodies and a t-cell engaging therapy |
| JP7537874B2 (ja) | 2017-05-19 | 2024-08-21 | シンダックス ファーマシューティカルズ， インコーポレイテッド | 併用療法 |
| GB201802486D0 (en) | 2018-02-15 | 2018-04-04 | Ucb Biopharma Sprl | Methods |
| PT3806898T (pt) | 2018-06-18 | 2025-12-02 | UCB Biopharma SRL | Antagonista de gremlin-1 para utilização no tratamento do cancro |
| WO2020059480A1 (ja) * | 2018-09-18 | 2020-03-26 | 株式会社カネカ | 固定化微生物の製造方法及びそれを用いたアミノ酸の製造方法 |
| KR20260014044A (ko) | 2018-10-16 | 2026-01-29 | 유씨비 바이오파마 에스알엘 | 중증근무력증의 치료 방법 |
| EP3947457A1 (de) | 2019-03-26 | 2022-02-09 | ASLAN Pharmaceuticals Pte Ltd | Behandlung mit verwendung von anti-il-13r-antikörper oder bindefragment davon |
| GB201919061D0 (en) | 2019-12-20 | 2020-02-05 | Ucb Biopharma Sprl | Multi-specific antibody |
| GB201919058D0 (en) | 2019-12-20 | 2020-02-05 | Ucb Biopharma Sprl | Multi-specific antibodies |
| GB201919062D0 (en) | 2019-12-20 | 2020-02-05 | Ucb Biopharma Sprl | Antibody |
| GB202001447D0 (en) | 2020-02-03 | 2020-03-18 | Ucb Biopharma Sprl | Antibodies |
| JP2023547795A (ja) | 2020-10-15 | 2023-11-14 | ユーシービー バイオファルマ エスアールエル | Ｃｄ４５を多量体化する結合分子 |
| WO2022089767A1 (en) | 2020-11-02 | 2022-05-05 | UCB Biopharma SRL | Use of anti-trem1 neutralizing antibodies for the treatment of motor neuron neurodegenerative disorders |
| KR20230118128A (ko) | 2020-12-07 | 2023-08-10 | 유씨비 바이오파마 에스알엘 | 인터루킨-22에 대한 항체 |
| EP4255926A1 (de) | 2020-12-07 | 2023-10-11 | UCB Biopharma SRL | Multispezifische antikörper und antikörperkombinationen |
| WO2022186772A1 (en) | 2021-03-01 | 2022-09-09 | Aslan Pharmaceuticals Pte Ltd | TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF |
| WO2022186773A1 (en) | 2021-03-01 | 2022-09-09 | Aslan Pharmaceuticals Pte Ltd | TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION |
| EP4067381A1 (de) | 2021-04-01 | 2022-10-05 | Julius-Maximilians-Universität Würzburg | Neue tnfr2-bindende moleküle |
| JP2024516305A (ja) | 2021-05-03 | 2024-04-12 | ユーシービー バイオファルマ エスアールエル | 抗体 |
| GB202111905D0 (en) | 2021-08-19 | 2021-10-06 | UCB Biopharma SRL | Antibodies |
| WO2023048651A1 (en) | 2021-09-27 | 2023-03-30 | Aslan Pharmaceuticals Pte Ltd | Method for treatment of moderate to severe atoptic dematitis |
| WO2023048650A1 (en) | 2021-09-27 | 2023-03-30 | Aslan Pharmaceuticals Pte Ltd | TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF |
| GB202115122D0 (en) | 2021-10-21 | 2021-12-08 | Dualyx Nv | Binding molecules targeting IL-2 receptor |
| WO2023075702A1 (en) | 2021-10-29 | 2023-05-04 | Aslan Pharmaceuticals Pte Ltd | Anti-il-13r antibody formulation |
| WO2023140780A1 (en) | 2022-01-24 | 2023-07-27 | Aslan Pharmaceuticals Pte Ltd. | Method of treating inflammatory disease |
| TW202337905A (zh) | 2022-02-23 | 2023-10-01 | 新加坡商亞獅康私人有限公司 | 抗il13r抗體之糖基化形式 |
| GB202210679D0 (en) | 2022-07-21 | 2022-09-07 | Dualyx Nv | Binding molecules targeting il-12rb2 |
| EP4590335A1 (de) | 2022-08-26 | 2025-07-30 | ASLAN Pharmaceuticals Pte Ltd | Hochkonzentrierte anti-il13r-antikörperformulierung |
| EP4594352A1 (de) | 2022-09-06 | 2025-08-06 | ASLAN Pharmaceuticals Pte Ltd | Behandlung von schlafverlust oder schlafstörung bei dermatitispatienten |
| GB202318820D0 (en) | 2023-12-08 | 2024-01-24 | UCB Biopharma SRL | Antibodies |
| WO2025238133A1 (en) | 2024-05-17 | 2025-11-20 | UCB Biopharma SRL | Multispecific antibody with binding specificity for il-11 and il-17 |
| WO2025238135A2 (en) | 2024-05-17 | 2025-11-20 | UCB Biopharma SRL | Antibody with binding specificity for il-11 |
| WO2026027660A1 (en) | 2024-08-02 | 2026-02-05 | UCB Biopharma SRL | Formulations of anti-gremlin-1 antibodies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3925157A (en) * | 1972-07-12 | 1975-12-09 | Pfizer | Immobilized enzymes |
| GB1400468A (en) * | 1972-07-22 | 1975-07-16 | Beecham Group Ltd | Enzyme preparation and use thereof |
| US4732851A (en) * | 1982-03-16 | 1988-03-22 | Purification Engineering, Inc. | Immobilization of cells with a polyazetidine prepolymer |
| US4436813A (en) * | 1982-03-16 | 1984-03-13 | Purification Engineering, Inc. | Immobilized microbial cell composition for making L-aspartic acid |
| DK152764C (da) * | 1985-06-14 | 1988-10-03 | Novo Industri As | Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt |
-
1987
- 1987-07-01 DK DK336987A patent/DK336987D0/da unknown
-
1988
- 1988-06-30 DE DE88306038T patent/DE3886280T2/de not_active Expired - Fee Related
- 1988-06-30 ES ES88306038T patent/ES2061656T3/es not_active Expired - Lifetime
- 1988-06-30 EP EP88306038A patent/EP0297912B1/de not_active Expired - Lifetime
- 1988-06-30 AT AT88306038T patent/ATE98689T1/de not_active IP Right Cessation
- 1988-07-01 JP JP63505497A patent/JP2641934B2/ja not_active Expired - Lifetime
- 1988-07-01 KR KR1019890700356A patent/KR970000186B1/ko not_active Expired - Fee Related
- 1988-07-01 WO PCT/DK1988/000108 patent/WO1989000195A1/en not_active Ceased
-
1989
- 1989-03-01 DK DK097189A patent/DK160843C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK97189D0 (da) | 1989-03-01 |
| DK160843C (da) | 1991-10-14 |
| DE3886280T2 (de) | 1994-03-31 |
| KR890701737A (ko) | 1989-12-21 |
| EP0297912A3 (en) | 1990-01-10 |
| ES2061656T3 (es) | 1994-12-16 |
| DE3886280D1 (de) | 1994-01-27 |
| DK97189A (da) | 1989-03-01 |
| EP0297912B1 (de) | 1993-12-15 |
| WO1989000195A1 (en) | 1989-01-12 |
| DK336987D0 (da) | 1987-07-01 |
| JP2641934B2 (ja) | 1997-08-20 |
| JPH01503677A (ja) | 1989-12-14 |
| KR970000186B1 (ko) | 1997-01-06 |
| EP0297912A2 (de) | 1989-01-04 |
| DK160843B (da) | 1991-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3886280D1 (de) | Immobilisierungsverfahren. | |
| DE3884016D1 (de) | Enzym-Immobilisierung und Bioaffinitätstrennungen mit Perfluorcarbon-Polymer-Trägern. | |
| EP0138833A4 (de) | Methoden zur Ermittlung der Lebensfähigkeit von Zellen und Vorrichtung zu ihrer Durchführung. | |
| DK521286D0 (da) | Modificerede, polymere overflader og fremgangsmaade til fremstilling deraf | |
| HU9300275D0 (en) | Method for binding emzyme in shape of crystal of spatial network structure | |
| NO902026L (no) | Poroest polymert material og fremgangsmaate og apparat for dets fremstilling. | |
| DE69434497D1 (de) | Verwendung von alpha-1,4-glukanlyase zur herstellung von 1,5 d-anhydrofruktose | |
| PL267910A1 (en) | Constant catalyst applied for stereospecific polymerization of alfa-olefins,the method of its manufacture and the method of alfa-olefins polymerization in the presence of that catalyst | |
| ATE68525T1 (de) | Verfahren zur immobilisierung geloester eiweissstoffe. | |
| DE3382425D1 (de) | Immobilisierte mikrobenzellen und verfahren zu deren herstellung und deren anwendung. | |
| DE3779905D1 (de) | Zellkulturtraeger. | |
| GB2151636B (en) | Reactive polymer, method for manufacture thereof and use thereof | |
| DE3782534D1 (de) | Pechbasierte kohlenstoffasern mit hohem elastizitaetsmodul und verfahren zu deren herstellung. | |
| DE3362885D1 (en) | Polymerizable, optically active polymer and process for preparing polymerizable polymer | |
| AU8217387A (en) | Process and device for the cultivation of immobilized or adherent mammalian cells, and the use thereof in the preparation of proteins | |
| IL70840A (en) | Cell culture apparatus,immobilized cell composite and process for preparation of the composite | |
| GR3009564T3 (de) | ||
| EP0222289A3 (en) | Process for the immobilization of biological material, particulate coagulates containing an immobilized biological material and their use as catalysts | |
| EP0137205A3 (de) | Verfahren zur Herstellung von Polymeren in Teilchenform | |
| DE3862788D1 (de) | Fluessige oxydationsmodifizierte ethylenische statistische copolymere, verfahren zur herstellung und deren verwendung. | |
| YU90576A (en) | Process for the immobilization of antigens, enzymes and enzyme-inhibitors | |
| DE3271040D1 (en) | Carrier-fixed proteases and their use in biotechnology | |
| AU2989989A (en) | Cell culture apparatus and process using an immobilized cell composite | |
| NO178743C (no) | Fremgangsmåte og emballeringsmateriale til regulering av veksten av mikroorganismer i et komplekst medium omfattende væske | |
| MX14264A (es) | Polimero de injerto soluble en alcali y procedimiento para su obtencion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |